SynBiotic SE (FRA:SBX)

Germany · Delayed Price · Currency is EUR

1.032

-0.058 (-5.32%)

At close: Jul 31, 2026

-64.96% (1Y)

Market Cap	7.38M -63.9%
Revenue (ttm)	14.86M +171.5%
Net Income	-9.72M
EPS	-1.66
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	1.142
Previous Close	1.090
Day's Range	1.032 - 1.142
52-Week Range	1.002 - 3.645
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 17, 2026

About SynBiotic SE

SynBiotic SE, together with its subsidiaries, engages in the pharmaceutical business in Germany and Europe. It is involved in the cultivation, research, development, production, and distribution of medicinal cannabis; industrial hemp; and cannabidiol and cannabinoid-based products. The company was incorporated in 2024 and is based in Düsseldorf, Germany. [Read more]

Industry Pharmaceutical Preparations

Founded 2024

Employees 79

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol SBX

Financial Performance

In 2024, SynBiotic SE's revenue was 14.86 million, an increase of 269.31% compared to the previous year's 4.02 million. Losses were -9.72 million, -8.60% less than in 2023.

Financial Statements